What's breaking now, across thousands of outlets.
A woman with advanced ovarian cancer has become the first patient in the world to receive a pioneering new therapy, in what is being hailed as a "landmark moment".
We haven't written up this one. Sky News Tech has the full story — the link below goes straight to it.
Learn more about some of the long-term effects of taking melatonin as an adult or a child.
The positive vote came despite persistent concerns from FDA scientists and positions the company to bounce back from two earlier rejections.
People often take antihistamines for eczema, but a large-scale meta-analysis now debunks their effectiveness and advises readers on treatments to use instead.
Influencer marketing represents a nearly $44 billion dollar industry that’s set to surpass traditional media, but a stigma around its personalities and economics still persists. Should it?
(MedPage Today) -- In the wake of a surprise FDA advisory committee vote on Thursday, the third time could be the charm for RP1 (vusolimogene oderparepvec), a melanoma drug candidate that's already…
The team integrated high-resolution spatial transcriptomics, single-cell RNA sequencing, and chromatin-accessibility profiling across nine sequential stages of lung colonization in mouse models.
